Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation
HJ Kolb… - Vox …, 1998 - Wiley Online Library
Allogeneic bone marrow transplantation is an effective treatment of leukemia. Intensive
chemo‐and radiotherapy used for conditioning and T‐cells of the graft contribute to the …
chemo‐and radiotherapy used for conditioning and T‐cells of the graft contribute to the …
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party …
HJ Kolb, A Schattenberg, JM Goldman, B Hertenstein… - 1995 - ashpublications.org
The immune reactivity of allogeneic lymphocytes plays a major role in the control of
leukemia after bone marrow transplantation. In patients with recurrent leukemia after marrow …
leukemia after bone marrow transplantation. In patients with recurrent leukemia after marrow …
Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.
J Szer, AP Grigg, GL Phillips… - Bone Marrow …, 1993 - europepmc.org
Four patients with acute myeloid leukaemia relapsed within 6 months of allogeneic BMT.
Three patients were treated with cytosine arabinoside and amsacrine while the fourth …
Three patients were treated with cytosine arabinoside and amsacrine while the fourth …
Donor leukocyte transfusions for leukemic relapse
F van Rhee, HJ Kolb - Current Opinion in Hematology, 1995 - journals.lww.com
Treatment of recurrent leukemia after bone marrow transplantation with the transfusion of
lymphocytes from the marrow donor has been successful in a majority of patients with …
lymphocytes from the marrow donor has been successful in a majority of patients with …
Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.
DL Porter, MS Roth, SJ Lee, C McGarigle… - Bone marrow …, 1996 - europepmc.org
Relapse remains a significant problem after allogeneic bone marrow transplantation (BMT).
For patients with relapsed chronic myelogenous leukemia (CML), infusions of donor …
For patients with relapsed chronic myelogenous leukemia (CML), infusions of donor …
Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic …
Fourteen patients with chronic myeloid leukemia (CML) relapsing after allogeneic bone
marrow transplant (BMT) were treated with leukocyte transfusions from the original marrow …
marrow transplant (BMT) were treated with leukocyte transfusions from the original marrow …
Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow …
WR Drobyski, MS Roth, SN Thibodeau… - Bone marrow …, 1992 - europepmc.org
Donor leukocyte infusions were administered to a patient who had relapsed with chronic
myelogenous leukemia after having failed two successive HLA-matched allogeneic bone …
myelogenous leukemia after having failed two successive HLA-matched allogeneic bone …
Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
S Slavin, E Naparstek, A Nagler… - Experimental …, 1995 - europepmc.org
Allogeneic bone marrow transplantation (BMT) is the treatment of choice for hematologic
malignancies resistant to conventional chemotherapy and for patients who are at high risk …
malignancies resistant to conventional chemotherapy and for patients who are at high risk …
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host …
S Shiobara, S Nakao, M Ueda, H Yamazaki… - Bone marrow …, 2000 - nature.com
To clarify the role of donor leukocyte infusion (DLI) in the treatment of leukemia relapsing
after allo-BMT, data from 100 patients were collected from 46 facilities in Japan and …
after allo-BMT, data from 100 patients were collected from 46 facilities in Japan and …
Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia
F Keil, OA Haas, G Fritsch, P Kalhs… - Blood, The Journal …, 1997 - ashpublications.org
We assessed the chimerism of CD34+ bone marrow cells before donor leukocyte infusion
(DLI) on nine occasions in seven patients with leukemic relapse after allogeneic marrow …
(DLI) on nine occasions in seven patients with leukemic relapse after allogeneic marrow …